Tropical Diseases, Travel Medicine and Vaccines最新文献

{"title":"Current update on malaria in pregnancy: a systematic review.","authors":"Awoke Minwuyelet, Delenasaw Yewhalaw, Melkamu Siferih, Getnet Atenafu","doi":"10.1186/s40794-025-00248-1","DOIUrl":"10.1186/s40794-025-00248-1","url":null,"abstract":"<p><strong>Background: </strong>Malaria during pregnancy poses significant risks to both the mother and the developing fetus. For pregnant women, the infection can result in severe illness and even death. Parasite sequestration in the placenta can cause maternal anemia and increase the risk of mortality both during and after childbirth. Malaria is also a major contributor to stillbirths and preterm births. Infected placental tissue can impede fetal growth, resulting in low birth weight, which is linked to delayed growth and cognitive development in the child. Furthermore, malaria during pregnancy remains a major contributor to perinatal, neonatal, and infant mortality.</p><p><strong>Objectives: </strong>To review the epidemiological patterns of malaria in pregnancy and its impact on maternal and neonatal health, and to analyze the availability and effectiveness of drug treatment options.</p><p><strong>Methods: </strong>Relevant articles published only in English were searched using electronic databases such as PubMed, Web of Science, Scopus, and Pro-Quest. Keywords including \"'malaria in pregnancy\", \"placental malaria\", \"congenital malaria\", \"treatment options\", and \"nutrition intervention and intermittent preventive treatment\" were used in combination. Of the total of 4,486 articles identified, 139 articles were ultimately included. Whereas, others were excluded due to duplication, irrelevant abstract, title, and quality assessment.</p><p><strong>Results: </strong>From 139 included studies, 47 focused on epidemiology of malaria in pregnancy, 58 on its impact and 16 on treatment options and 18 on nutrition intervention and intermittent treatment. Plasmodium falciparum is the leading cause of complications in pregnant women and is primarily found in Africa, while P.vivax is recognized as an emerging global threat, and causing serious consequences. Other species, such as P.knowlesi, P.ovale, and P.malariae are less common. Malaria prevalence in pregnancy can reach 60% in sub-Saharan Africa and 36% globally, with placental malaria affecting up to 28% of cases. The disease causes serious complications such as maternal anemia, premature birth, and low birth weight, severe anemia and increased maternal and infant mortality. Prevention strategies like intermittent preventive treatment (IPTp), insecticide-treated nets (ITNs) and Indoor residual spray (IRS) are essential. Early diagnosis and treatment can reverse adverse effects on placental and congenital function. Artesunate is recommended for severe malaria in all trimesters. Even resistance to chloroquine reported in some areas, it is the drug of choice for uncomplicated P.vivax infections.</p><p><strong>Conclusions: </strong>Malaria during pregnancy significantly impacts maternal and fetal health, leading to anemia, growth restriction, preterm birth, and neonatal death. Infants born to mothers with malaria are more likely to contract the disease. Further research and improved treatment strategies are","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"11 1","pages":"14"},"PeriodicalIF":2.4,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12096600/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144120940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The role of mRNA vaccines in infectious diseases: a new era of immunization.","authors":"Kesaobaka Batisani","doi":"10.1186/s40794-025-00246-3","DOIUrl":"https://doi.org/10.1186/s40794-025-00246-3","url":null,"abstract":"<p><p>The emergence of messenger RNA (mRNA) vaccines has marked a seminal shift in the field of immunization, heralding an era characterized by unprecedented speed and efficacy in the face of infectious diseases. The global crisis caused by the COVID-19 pandemic catalyzed the rapid development and deployment of two leading mRNA vaccines, Comirnaty and SpikeVax, showcasing not only the technological promise of mRNA, but also its transformative potential in public health strategies. This study seeks to provide an in-depth exploration of the foundational elements of mRNA vaccine technology, elucidate its unique advantages over traditional vaccine platforms, analyze the existing challenges that public health officials face, and envision future applications that extend far beyond current expectations. Through this exploration, we advocate for the integration of mRNA technology into existing public health frameworks to enhance global health security and adaptability in the face of emerging infectious threats.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"11 1","pages":"12"},"PeriodicalIF":2.4,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12079950/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144080121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"\"Are they going to recollect who they need to contact?\": understanding sexually transmitted infection transmission risks among older Canadians who winter in the United States.","authors":"Olivia Nieves Echevarria, John Pickering, Valorie A Crooks, Jeremy Snyder, Trudie Milner","doi":"10.1186/s40794-025-00245-4","DOIUrl":"https://doi.org/10.1186/s40794-025-00245-4","url":null,"abstract":"<p><strong>Background: </strong>Sexually transmitted infections are on the rise in older populations globally, including among older travellers. International retirement migrants are older people who have retired from the workforce and travel abroad seasonally, typically during the winter months in their home countries. The transnational nature of this practice may challenge public health efforts to control the spread of sexually transmitted infection and encourage treatment. This study focuses on Yuma, Arizona, a popular destination for Canadian international retirement migrants who winter in the United States, to examine the sexual health risks associated with their seasonal travel.</p><p><strong>Methods: </strong>Utilizing a qualitative case study approach, this research involved semi-structured interviews conducted remotely with key informants in Yuma (n = 10) who held various health care and administrative roles. Participants provided insights into sexual health risks based on their extensive interactions with Canadian seasonal migrants and their knowledge of the social dynamics within retirement communities. Interviews were transcribed verbatim, coded using NVivo software, and thematically analyzed to identify risk factors for sexually transmitted infections among Canadian international retirement migrants wintering in Yuma.</p><p><strong>Results: </strong>Findings revealed three main risks that may contribute to exposure to sexually transmitted infections and potential transmission: social dynamics within tight-knit retirement migrant communities that facilitate unsafe sexual practices (i.e., risky practices); barriers to accessing diagnostic services, such as costs and lack of established local care (i.e., risky care access); and challenges in following standard treatment and public health protocols due to logistical difficulties in ensuring follow-up (i.e., risky treatment decisions). Key informants noted that lifestyle choices, including the use of alcohol and drugs, can exacerbate these risks. Health care access barriers driven by travel health insurance and mobility limitations further complicate the diagnosis and treatment of sexually transmitted infections for Canadian international retirement migrants while abroad.</p><p><strong>Conclusions: </strong>This study highlights the complex interplay of social behaviours and health care barriers that heighten the risk of sexually transmitted infection transmission among Canadian retirement migrants in the transnational context of Yuma. Extended diagnostic and treatment services, comprehensive sexual health education in pre- and post-travel consultations, as well as inclusive travel health insurance coverage could significantly improve the sexual health outcomes for this population.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"11 1","pages":"11"},"PeriodicalIF":2.4,"publicationDate":"2025-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12057024/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144034217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Current epidemiological status of mosquito-borne arboviruses in Gulf countries: a systematic review and meta-analysis.","authors":"Khalid Hajissa, Mutiat Hammed-Akanmu, Hussain Omar Alfaqih, Ahmad A Alshehri, Mohammed Dauda Goni, Maha Al-Asmakh","doi":"10.1186/s40794-025-00247-2","DOIUrl":"https://doi.org/10.1186/s40794-025-00247-2","url":null,"abstract":"<p><strong>Background: </strong>Mosquito-borne viral (MBV) infections caused by dengue virus (DENV), Rift Valley fever virus (RVFV), West Nile virus (WNV), and chikungunya virus (CHIKV) pose a significant global public health concern. The aim of this systematic review is to summarise the reported prevalence data for these viruses in Gulf countries.</p><p><strong>Methods: </strong>A web search in four electronic databases (Scopus, PubMed, Google Scholar, and Web of Science) was conducted, and forty-four eligible studies were fulfilled the selection criteria and were therefore included in this study. The Pooled prevalence of MBVs was estimated using a random-effects model. The heterogeneity was assessed using Cochrane Q test and I² test, while publication bias was evaluated using Egger's test.</p><p><strong>Results: </strong>Using meta-analysis of proportions, the pooled prevalence of MBVs in Gulf countries among 34,367 human and 19,062 Animal samples was estimated to be 22.5% (95% CI: 13.7-31.4) and 11.6% (95% CI: 0.5 - 22.7%), respectively. In human, DENV was the most predominant virus reported in 19 studies, with an overall pooled prevalence of 32.4%, followed by RVFV in 9 studies, with an infection rate of 10.1%, while WNV and CHIKV were only reported in two studies, with overall prevalence rates of 6.4% and 2.4%, respectively. On the other hand, the overall prevalence of WNV and RVFV in animals was estimated to be 27.7% and 1.5%, respectively.</p><p><strong>Conclusion: </strong>This review revealed that MBVs are highly prevalent among humans in Gulf countries but relatively low in animals. As a result, additional therapeutic and preventive measures are required. However, the study highlights the need for further studies and surveillance to precisely monitor the burden of these viruses in the region.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"11 1","pages":"13"},"PeriodicalIF":2.4,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12044787/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144043654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Psychiatric treatment outcomes of travelers admitted to a psychiatric hospital: a retrospective analysis.","authors":"Achim Burrer, Tobias R Spiller, Jose Marie Koussemou, Georgios Schoretsanitis, Philipp Homan, Steffi Weidt, Erich Seifritz, Stefan Vetter, Stephan T Egger","doi":"10.1186/s40794-024-00244-x","DOIUrl":"https://doi.org/10.1186/s40794-024-00244-x","url":null,"abstract":"<p><strong>Background: </strong>Travel-related psychiatric disorders range from anxiety disorders to mood disorders, substance abuse, and psychosis. Various travel-associated factors such as dehydration, time shifts, changes in social structures or stress factors are discussed for these disorders. There is a lack of knowledge concerning the quality and outcome of psychiatric treatment in travelers hospitalized abroad. This study is the first to compare outcome of treatment in psychiatric travelers to domestic patients.</p><p><strong>Methods: </strong>We analyzed electronic health records of travelers in the Psychiatric University Hospital Zurich from January 2013 to December 2020. Each traveler was matched with one Swiss national and one migrant using propensity score matching.</p><p><strong>Results: </strong>Travelers showed inferior CGI-I scores at discharge (F(2,969) = 5.72; p = 0.003). The length of stay was shorter (F(2,969) = 38.74:p < 0.001) for travelers (9.69 ± 14.31) than for Swiss nationals (24.69 ± 29.42) and migrants (24.74 ± 28.62). The transfer rate to another hospital was higher (X²(2,972) = 50.85: p < 0.001) for travelers (79, 29.4%) than for Swiss nationals (25, 7.7%) or migrants (26, 8.0%).</p><p><strong>Conclusions: </strong>Psychiatric treatments of hospitalized travelers showed a lower symptom improvement while presenting a more severe overall condition at discharge. Length of stay was shorter compared to domestic patients. Admission of travelers was initiated involuntarily more frequently. This most closely reflects the theory that travelers are typically hospitalized in severe emergencies and are promptly discharged or repatriated after an initial treatment response has been achieved.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"11 1","pages":"9"},"PeriodicalIF":2.4,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12042500/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143996936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evidence of pathogens associated with travelers' diarrhea in Thailand: a systematic review.","authors":"Wanida Mala, Kwuntida Uthaisar Kotepui, Frederick Ramirez Masangkay, Kinley Wangdi, Polrat Wilairatana, Manas Kotepui","doi":"10.1186/s40794-024-00243-y","DOIUrl":"https://doi.org/10.1186/s40794-024-00243-y","url":null,"abstract":"<p><strong>Background: </strong>Thailand, a major tourist destination, exhibits variations in sanitation and food safety practices that can lead to cases of travelers' diarrhea (TD) caused by a plethora of pathogens. This systematic review synthesizes data on the pathogens associated with TD in Thailand, providing valuable insights into pathogen diversity and distribution, traveler profiles, and geographical regions of concern.</p><p><strong>Methods: </strong>This systematic review followed the PRISMA guidelines and was registered in PROSPERO (CRD42022346014). A comprehensive search was conducted across PubMed, Embase, Scopus, MEDLINE, and Journals@Ovid databases. The search included terms related to \"diarrhea,\" \"travelers,\" and \"Thailand,\" without restrictions on publication date. Eligible studies focused on travelers to Thailand who developed diarrhea with identified specific pathogens. Data was extracted and synthesized using a narrative approach. The risk of bias was assessed using the Joanna Briggs Institute (JBI) Critical Appraisal Checklist.</p><p><strong>Results: </strong>A total of 15 studies met the eligibility criteria, identifying that pathogens related to TD in Thailand were bacteria, particularly enterotoxigenic Escherichia coli (ETEC) (80%), followed by Campylobacter jejuni (33.3%) and Salmonella spp. (40%). Viral pathogens such as rotavirus and norovirus were also notable, with Giardia spp. being the most identified parasite. Pathogen distribution varied across different regions of Thailand, with tourism hubs such as Bangkok, Chiang Mai, Phuket, and Krabi reporting a broader range of infections.</p><p><strong>Conclusions: </strong>This systematic review highlights the diverse range of pathogens associated with TD in Thailand, with bacterial pathogens, specifically ETEC, being the predominant cause in most studies. The findings underscore the importance of preventive measures, such as improved hygiene practices and food safety awareness, especially in high-risk tourist areas. Further research is needed to understand better the risk factors contributing to TD and to develop targeted interventions for prevention.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"11 1","pages":"8"},"PeriodicalIF":2.4,"publicationDate":"2025-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12036122/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144049998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Perceptions, attitudes, practices, and factors associated with COVID-19 vaccination among travelers in the Democratic Republic of the Congo.","authors":"Harry César Kayembe, Germain Kapour, Papy Ansobi, Aymen Jarboui, Alexis Kalimba Bantu, Glodi Elumbu, Nicodème Nkutu, Eric Mbuyi, Abraham Moyo, Vincent Mbatu, Archilène Nto, Marc Ngondu, Benito Muhindo, Serge Lukunku, Orman Mboyolo, Traoré Ibrahima Sory, Didier Bompangue","doi":"10.1186/s40794-024-00240-1","DOIUrl":"https://doi.org/10.1186/s40794-024-00240-1","url":null,"abstract":"<p><strong>Background: </strong>Vaccination against COVID-19 has been the primary public health measure implemented to limit the spread of the disease. However, there is still considerable scope for improvement in vaccine coverage, particularly in sub-Saharan African countries. The factors influencing the acceptance or reluctance of the COVID-19 vaccine have been widely studied, but there is a gap in the literature with regard to dynamic populations, particularly travelers, who are one of the priority target groups for vaccination. This study assessed the perceptions, attitudes and practices regarding the COVID-19 vaccine, and explored factors associated with vaccination status among travelers.</p><p><strong>Methods: </strong>A cross-sectional survey was conducted at several points of entry (PoEs) selected for six survey sites (N'djili airport, Ngobila beach, Lufu, Boma, Moanda, and Kananga), located in three provinces of the Democratic Republic of the Congo (Kinshasa, Kongo Central and Kasaï Central), from February 20 to March 05, 2023. The data were summarized and logistic regression models were performed to assess factors associated with vaccination status.</p><p><strong>Results: </strong>A total of 2742 travelers were included in this survey. Of these, 54% had received at least one dose of COVID-19 vaccine. Multivariable logistic regression analyses revealed that that several factors were significantly associated with vaccination status. These included age (under 60 years), marital status (single), occupation (other than healthcare worker), mode of travel (other than airplane), and poor perceptions of the vaccine. The most frequently cited reasons for vaccination among respondents who had received the vaccine were the prevention of COVID-19 infection and the ease of travel. In contrast, unvaccinated participants expressed greater concern about the safety and effectiveness of the vaccine, as well as vaccine-related side effects. Furthermore, travel disruption and inappropriate vaccination sites have been identified as significant obstacles to the acceptance of vaccination at the PoEs.</p><p><strong>Conclusions: </strong>It is essential that awareness initiatives address concerns and misconceptions about vaccine safety and effectiveness. The influence of social media platforms may be harnessed for the dissemination of accurate information from the most trusted information sources, including healthcare professionals, to the target population. In addition, accompanying measures should be considered to facilitate vaccination compliance at different PoEs.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"11 1","pages":"10"},"PeriodicalIF":2.4,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11998446/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144000408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Knowledge, attitude, practice, and barriers among physicians in the Middle East and North Africa region toward influenza vaccination for the high-risk group of patients: a cross-sectional study.","authors":"Saadi M Saleh, Alaa Aljamala, Dina Hafez, Mosab Abu Shqeer, Islam Abukandil, Weam Aldiban, Azza Baraka","doi":"10.1186/s40794-024-00241-0","DOIUrl":"10.1186/s40794-024-00241-0","url":null,"abstract":"<p><strong>Background: </strong>The influenza vaccine is a cost-effective measure to reduce morbidity and mortality, especially for high-risk patients. Healthcare providers have an essential role in patients' education about vaccines. This study aims to examine physicians' understanding, perceptions, and practices regarding influenza vaccination in the Middle East and North Africa (MENA) region for high-risk patients.</p><p><strong>Methods: </strong>We conducted a multinational cross-sectional study in 21 countries in MENA region from July 10th to September 10th, 2023. Data were collected using an online self-administered survey distributed through different social media platforms. We used a valid questionnaire designed to determine the knowledge, attitude, and practice of physicians toward influenza vaccination. A multivariable binomial logistic regression analysis was conducted to identify significant predictors for offering the influenza vaccine.</p><p><strong>Results: </strong>In this study, which involved 2017 physicians (the mean (SD) age was 29 (± 6.2); 52% were males), the majority expressed a low to medium level of knowledge about influenza vaccination, with only 4% displaying a high level of knowledge. Regarding attitude, the majority (n = 1511, 74.9%) were quite concerned. However, only (n = 509, 25.4%) offered the vaccine to patients. The main predictors for offering the vaccine were age (adjusted odd ratio (AOR) = 1.036, 95%CI = 1.003-1.07, p = 0.031), male sex (AOR = 1.39, 95%CI = 1.09-1.77, p = 0.007), living in upper-middle-income countries (AOR = 3.14, 95%CI = 2.1-4.7, p < 0.001), having PhD degree (AOR = 3.15, 95%CI = 1.47-6.71, p = 0.003), being a senior resident (AOR = 2.005, 95%CI = 1.147-3.5, p = 0.015), working two to five shifts per week (AOR = 1.55, 95%CI = 1.02-2.35, p = 0.04), working more than five shifts per week (AOR = 1.75, 95%CI = 1.06- 2.88, p = 0.027), attitude (AOR = 1.33, 95%CI = 1.243- 1.44, p < 0.001), following these practices regarding influenz vaccination with the other office staff: Encourage and offer (AOR = 5.73, 95%CI = 4.11- 8.007, p < 0.001), require but do not offer (AOR = 3.73, 95%CI = 2.59- 5.38, p < 0.001), and require and offer the influenza vaccine (AOR = 6.79, 95%CI = 4.88- 9.45, p < 0.001) to the office staff. The main barriers to influenza vaccination were unawareness of vaccine availability (32%), cost (25%), and forgetfulness (23.4%).</p><p><strong>Conclusions: </strong>Approximately half of the physicians were knowledgeable about the flu vaccine, but practice was deficient and impeded by barriers like unawareness and forgetfulness.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"11 1","pages":"6"},"PeriodicalIF":2.4,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11959996/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143754436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Putting the mouth back in the body - the neglected area of dental and oral travel health.","authors":"Irmgard L Bauer","doi":"10.1186/s40794-024-00242-z","DOIUrl":"10.1186/s40794-024-00242-z","url":null,"abstract":"<p><p>The lack of dental travel health care has been deplored for some time. Travel medicine's remit is to prepare people for travel. People travel with their mouth firmly in their body, yet the mouth's wellbeing does not rate a mention. This article represents the first exploration of a range of topics relevant to an until now neglected, yet potentially highly important, area of health care. A range of dental mishaps can occur while away from home, from simple toothache to accidents, serious emergencies, or restoration failures. Other problems originate in unwise behaviour, including holiday-inspired body modifications.Unless there is pain, teeth are typically not thought about much. However, examining the practical side of dental hygiene during travels, several overlooked and perhaps surprising topics emerge that - through the travel lens - take on a different and important role: the oral microbiome, toothbrush hygiene, the toilet plume, and traveller diarrhoea. Based on this discussion, recommendations are made for clinical practice, education, and further research.The historical chasm between dentistry and medicine, despite long-standing calls for change, does not seem to go away and impairs holistic high quality travel health care. Travel medicine can bypass this unproductive division. It has the unique opportunity to be the first medical specialty cooperating closely with dentists to bridge this gap by providing quality travel health care to travellers with all their body parts attached.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"11 1","pages":"7"},"PeriodicalIF":2.4,"publicationDate":"2025-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11909844/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143634745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impact of COVID-19 on a medium-sized travel medicine clinic in eastern Pennsylvania, USA.","authors":"Pravallika Palwai, Marcelo Gareca, Sowmya R Rao, Mark C Knouse","doi":"10.1186/s40794-024-00239-8","DOIUrl":"10.1186/s40794-024-00239-8","url":null,"abstract":"<p><strong>Background: </strong>The COVID-19 pandemic (COVID) disrupted international travel. We sought to determine the impact of the COVID-19 pandemic on patient volume, traveler demographics, and income of our medium-sized travel clinic in Pennsylvania, USA.</p><p><strong>Methods: </strong>We extracted de-identified pre-travel data on 3,510 pre-travel consultations for adults during: Pre-COVID-19 (January 2018-December 2019), Early COVID-19 (April 2020-March 2022) and Late COVID-19 (April 2022-March 2023). We compared traveler demographics, destinations, purpose of travel, medical conditions, and number of vaccinations administered over time, and our clinic's revenue obtained from our financial database (TruSource) for the Pre, Early and Late COVID-19 periods.</p><p><strong>Results: </strong>We observed 84% and 85% relative decreases in traveler volume and revenue respectively from the Pre-COVID-19 to the Early COVID-19 period. The decrease (16-11%) in volume was highest for travelers over 65 years of age. Of those that sought care during Early COVID-19, a fewer proportion of travelers had multiple co-morbid conditions and were taking chronic medications. Trip length increased and there was a significant increase in travel to Africa. Travel to visit friends or family and for service work also increased during Early-COVID-19 (32.9%) versus Pre-COVID-19 (19.8%). Clinic volume and revenue began to increase in Late COVID-19 but did not return to Pre-COVID levels.</p><p><strong>Conclusions: </strong>The COVID pandemic resulted in a large reduction in patient volume and revenue in our academic-based Pennsylvania travel clinic. We saw substantial changes in our traveler demographics, destinations, as well as reasons and durations of travel. Smaller travel clinics will need to have plans in place in order to survive the next pandemic and better serve their pre-travel populations.</p>","PeriodicalId":23303,"journal":{"name":"Tropical Diseases, Travel Medicine and Vaccines","volume":"11 1","pages":"5"},"PeriodicalIF":2.4,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11871799/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143531898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}